Although surgery cures most patients who have early-stage medullary thyroid carcinoma, disease can persist, recur or metastasize. This affects both quality of life and mortality. This article outlines current treatment strategies as well as various novel targets that are being investigated for therapies, especially for patients with distant metastases.
- Martin Schlumberger
- Francesca Carlomagno
- Massimo Santoro